Dr. Sanders is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
Indianapolis, IN 46202Phone+1 317-274-7208Fax+1 317-274-0508
Education & Training
- University of WashingtonFellowship, Pediatric Pulmonology, 2006 - 2009
- McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2003 - 2006
- Northwestern University The Feinberg School of MedicineClass of 2003
Certifications & Licensure
- IN State Medical License 2016 - 2025
- IL State Medical License 2003 - 2017
- WI State Medical License 2009 - 2017
- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- 1 citationsImpact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA.Elizabeth A Cromwell, Josh S Ostrenga, Don B Sanders, Wayne Morgan, Carlo Castellani
The European Respiratory Journal. 2024-11-01 - 1 citationsCharacteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor.Don B Sanders, Nicole Mayer-Hamblett, Margaret Rosenfeld, Deepika Polinieni, Elliott Dasenbrook
Journal of Cystic Fibrosis. 2024-07-29 - 7 citationsAdjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.Oliver J McElvaney, Sonya L Heltshe, Katherine Odem-Davis, Natalie E West, Don B Sanders
Annals of the American Thoracic Society. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: